Develop and Evaluate of Integrated Interactive Self-care APP Among Hematopoietic Stem Cell Transplantation Patient

Kaohsiung Medical University

Status

Completed

Conditions

Self Efficacy

Application

Resilience

Mobile Health

Self-compassion

Hematopoietic Stem Cell Transplantations

Treatments

Device: integrated interactive self-care APP

Study type

Interventional

Funder types

Other

Identifiers

NCT06839183

MOST-111-2410-H-037-012 (Other Grant/Funding Number)

KMUHIRB-F(I)20210187

Details and patient eligibility

About

Background: More than 50,000 hematopoietic stem cell transplants are performed around the world every year. However, HSCT treatment time is long and the treatment methods are complex, and it has a significant impact on the patient's body and mind. Foreign studies have shown that using mobile technology for cancer symptom monitoring and self-care can effectively improve cancer patients' doctor-patient communication, symptom management, and self-care abilities. There are only 7 articles on foreign HSCT-related APPs or online smart projects.

Purpose: To evaluate the use of an integrated interactive self-care APP in hematopoietic stem cell transplant patients Methods: This study is a two-stage explanatory qualitative mixed study. The quantitative study in the second year adopts a non-randomized experimental research design. Pre-test and formal testing are repeated in two groups. The experimental group (APP) will be admitted first according to the patient's wishes. The number of participants will then be included in the control group. Each group is expected to receive 40 subjects. The experimental group will receive general routine care plus the use of an integrated interactive self-care APP. The control group will receive general routine care and will be filled out at 8-time points before and after transplantation. Self-efficacy, self-compassion, and resilience questionnaire.

Enrollment

80 patients

Sex

All

Ages

47+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Conscious, over 20 years old, and able to communicate in Mandarin or Taiwanese dialect.
Diagnosed via pathology report with one of the following cancers: acute myeloid leukemia, acute lymphoblastic leukemia, non-Hodgkin lymphoma, or multiple myeloma.
Requires HSCT (Hematopoietic Stem Cell Transplantation) treatment.
Possesses a smartphone.

Exclusion criteria